{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "marketState": "PREPRE", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "regularMarketChangePercent": -2.4330902, "regularMarketPrice": 12030.0, "exchange": "KOE", "shortName": "Genexine", "longName": "Genexine, Inc.", "exchangeTimezoneName": "Asia/Seoul", "market": "kr_market", "regularMarketTime": 1683873025, "regularMarketDayHigh": 12320.0, "regularMarketDayRange": "12010.0 - 12320.0", "regularMarketDayLow": 12010.0, "regularMarketVolume": 166860, "regularMarketPreviousClose": 12330.0, "bid": 12150.0, "ask": 12170.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 12230.0, "averageDailyVolume3Month": 307670, "averageDailyVolume10Day": 177563, "fiftyTwoWeekLowChange": 290.0, "fiftyTwoWeekLowChangePercent": 0.024701875, "fiftyTwoWeekRange": "11740.0 - 29730.77", "fiftyTwoWeekHighChange": -17700.77, "fiftyTwoWeekHighChangePercent": -0.5953687, "fiftyTwoWeekLow": 11740.0, "fiftyTwoWeekHigh": 29730.77, "earningsTimestamp": 1676026740, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "sharesOutstanding": 20551900, "fiftyDayAverage": 12781.8, "fiftyDayAverageChange": -751.7998, "fiftyDayAverageChangePercent": -0.058817994, "twoHundredDayAverage": 16758.123, "twoHundredDayAverageChange": -4728.123, "twoHundredDayAverageChangePercent": -0.28213918, "marketCap": 247239360512, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1252972800000, "priceHint": 2, "regularMarketChange": -300.0, "symbol": "095700.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Korea Bio Park Building B", "address2": "700 Daewangpangyo-ro Bundang-gu", "city": "Seongnam", "zip": "13488", "country": "South Korea", "phone": "82 3 1628 3200", "fax": "82 3 1628 3229", "website": "https://www.genexine.com", "industry": "", "sector": "", "longBusinessSummary": "Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. It develops hyFc platform, a proprietary technology designed to drive the discovery of various differentiated agonistic protein therapeutics; and the Immune Enhancing Technology, a therapeutic DNA vaccine technology. The company's product pipeline includes GX-H9, which is in Phase II clinical trials for the treatment of adult and pediatric growth hormone deficiency; GX-E2, which is in Phase II clinical trials for the treatment of induced anemia; GX-G3, which is in Phase II clinical trials to treat neutropenia; and GX-G6 that is in Phase I clinical trials for the treatment of diabetes. It is also developing GX-188E that is in Phase II clinical trials in combination with KEYTRUDA for the treatment of cervical cancer. Genexine, Inc. has a co-development partnership with Binex Co. Ltd. to develop COVID-19 vaccine. The company was formerly known as Genexine Co., Ltd. and changed its name to Genexine, Inc. in March 2013. Genexine, Inc. was founded in 1999 and is based in Seongnam, South Korea.", "fullTimeEmployees": 109, "companyOfficers": [{"maxAge": 1, "name": "Mr. Neil K.  Warma M.B.A.", "age": 59, "title": "Pres, CEO & Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jungwon  Woo Ph.D.", "title": "Pres & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Young-Chul  Sung Ph.D.", "age": 66, "title": "Founder & Chairman of the Scientific Advisory Board", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sung-June  Hong CPA", "title": "Exec. VP, CFO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jongsoo  Lee", "title": "Sr. Mang. of IR & PR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Hyun  Jin Park", "title": "EVP of Corp. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jae Chan  Park Ph.D.", "title": "Exec. VP of Alliance Operation", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kyu Don  Kim Ph.D.", "title": "Exec. VP of Bus.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sung Hee  Lee Ph.D.", "title": "Head of Bio Research Institute and Exec. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jong Sup  Park M.D., Ph.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}